Convergence of leptin and insulin signaling networks in obesity

Neurobiology of Obesity

Volumn , Issue , 2008, Pages 127-163

  Sutherland, Calum ^a   Ashford, Mike ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927958877     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511541643.006     Document Type: Chapter

References (249)

1. Ahmad, F., Considine, R. V., Bauer, T. L., Ohannesian, J. P., Marco, C. C. & Goldstein, B. J. (1997). Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism46, 1140–5.
2. Ahmed, Z. & Pillay, T. S. (2003). Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3 kinase-dependent signaling. Biochem. J. 371, 405–12.
3. Alessi, D. R. & Downes, C. P. (1998). The role of PI 3-kinase in insulin action. Biochim. Biophys. Acta1436, 151–64.
4. Andersson, U., Filipsson, K., Abbott, C. R. et al. (2004). AMPK plays a role in the control of food intake. J. Biol. Chem. 279, 12 005– 8.
5. Andreelli, F., Foretz, M., Knauf, C. et al. (2006). Liver adenosine monophosphateactivated kinase alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology147, 2432–41.
6. Bandyopadhay, G., Standaert, M. L., Zhao, L. et al. (1997). Activation of protein kinase C (a, b and f) by insulin in 3T3/L1 cells. J. Biol. Chem.272, 2551–8.
7. Banks, A. S., Davis, S. M., Bates, S. H. & Myers, M. G. Jr. (2000). Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275, 14 563–72.
8. Bates, S. H., Stearns, W. H., Dundon, T. A. et al. (2003). STAT3 signaling is required for leptin regulation of energy balance but not reproduction. Nature421, 856–9.
9. Baumann, H., Morella, K. K., White, D. W. et al. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA93, 8374–8.
10. Beebe, S. J., Redmon, J. B., Blackmore, P. F. & Corbin, J. D. (1985). Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. J. Biol. Chem. 260, 15 781–8.
11. Benomar, Y., Roy, A. F., Aubourg, A., Djiane, J. & Taouis, M. (2005). Cross down regulation of leptin and insulin receptor expression and signaling in a human neuronal cell line. Biochem. J.388, 929–39.
12. Benomar, Y., Wetzler, S., Larue-Achagiotis, C., Djiane, J., Tome, D. & Taouis, M. (2005). In vivo leptin infusion impairs insulin and leptin signaling in liver and hypothalamus. Mol. Cell. Endocrinol. 242, 59–66.
13. Beugnet, A., Tee, A. R., Taylor, P. M. & Proud, C. G. (2003). Regulation of targets of mTOR (mammalian target of rapamycin) signaling by intracellular amino acid availability. Biochem. J. 372, 555–66.
14. Bjorbaek, C., El-Haschimi, K., Frantz, J. D. & Flier, J. S. (1999). The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274, 30059–65.
15. Bjorbaek, C., Buchholz, R. M., Davis, S. M. et al. (2001). Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276, 4747–55.
16. Bogacka, I., Roane, D. S., Xi, X. et al. (2004).Expression levels of genes likely involved in glucose-sensing in the obese Zucker rat brain. Nutr. Neurosci. 7, 67–74.
17. Bost, F., Aouadi, M., Caron, L. & Binetruy, B. (2005). The role of MAPKs in adipocyte differentiation and obesity. Biochimie87, 51–6.
18. Bost, F., Aouadi, M., Caron, L. et al. (2005). The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes54, 402–411.
19. Bouloumie, A., Marumo, T., Lafontan, M. & Busse, R. (1999). Leptin induces oxidative stress in human endothelial cells. FASEB J. 13, 1231–8.
20. Bray, G. A., Lovejoy, J. C., Smith, S. R. et al. (2002). The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J. Nutr.132, 2488–91.
21. Brown, R. A. & Shepherd, P. R. (2001). Growth factor regulation of the novel class II phosphoinositide 3-kinases. Biochem. Soc. Trans.29, 535–7.
22. Bruning, J. C., Gautam, D., Burks, D. J. et al. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science289, 2122–5.
23. Burks, D. J., Font de Mora, J., Schubert, M. et al. (2000). IRS2 pathways integrate female reproduction and energy homeostasis. Nature407, 377–82.
24. Butler, M., McKay, R. A., Popoff, I. J. et al. (2002). Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes51, 1028–34.
25. Cantley, L. C. (2002). The PI 3-kinase pathway. Science296, 1655–7.
26. Cao, Q., Mak, K. M. & Lieber, C. S. (2006). Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2- dependent MAPK pathways. J. Cell. Biochem. 97, 188–97.
27. Carvalheira, J. B., Ribeiro, E. B., Folli, F., Velloso, L. A. & Saad, M. J. (2003). Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3 kinase-mediated signaling in rat liver. Biol. Chem. 384, 151–9.
28. Carvalheira, J. B., Torsoni, M. A., Ueno, M. et al. (2005). Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes. Res. 13, 48–57.
29. Chang, G. Q., Karatayev, O., Davydova, Z., Wortley, K. & Leibowitz, S. F. (2005). Glucose injection reduces neuropeptide Y and agouti-related protein expression in the arcuate nucleus: a possible physiological role in eating behavior. Mol. Brain Res. 135, 69–80.
30. Chang, L. & Karin M. (2001). Mammalian MAP kinase signaling cascades. Nature410, 37–40.
31. Chen, H., Charlat, O., Tartaglia, L. A. et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell84, 491–5.
32. Choudhury, A. I., Heffron, H., Smith, M. A. et al. (2005). The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J. Clin. Invest. 115, 940–50.
33. Chua, S. C. J., Chung, W. K., Wu-Peng, X. S. et al. (1996). Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science271, 994–6.
34. Chung, J., Kuo, C. J., Crabtree, G. R. & Blenis, J. (1992). Rapamycin-FKBP specifically blocks growth dependent activation of and signaling by the 70kDa S6 protein kinases. Cell69, 1227–36.
35. Clément, S., Krause, U., Desmedt, F. et al. (2001). The lipid phosphatase SHIP2 controls insulin sensitivity. Nature409, 92–7.
36. Cohen, B., Novick, D. & Rubinstein, M. (1996). Modulation of insulin activities by leptin. Science274, 1185–8.
37. Cone, R. D. (2005). Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571–8.
38. Considine, R. V., Sinha, M. K., Heiman, M. L. et al. (1996). Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–5.
39. Cota, D., Proulx, K., Smith, K. A. et al. (2006). Hypothalamic mTOR signaling regulates food intake. Science312, 927–30.
40. Dadke, S., Kusari, A. & Kusari, J. (2001). Phosphorylation and activation of proteintyrosine phosphatase (PTP) 1B by insulin receptor. Mol. Cell. Biochem. 221, 147–54.
41. Dent, P., Haser, W., Haystead, T. A., Vincent, L. A., Roberts, T. M. & Sturgill, T. W. (1992). Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science257, 1404–7.
42. Dickens, M., Svitek, C. A., Culbert, A. A., O’Brien, R. M. & Tavare, J. M. (1998). Central role for PI 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J. Biol. Chem. 273, 20 144–9.
43. Domin, J., Pages, F., Volinia, S. et al. (1997). Cloning of a human phosphoinositide 3- kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326, 139–47.
44. Duan, C., Li, M. & Rui, L. (2004). SH2-B promotes IRS1- and IRS2-mediated activation of the PI 3-kinase pathway in response to leptin. J. Biol. Chem. 279, 43 684–91.
45. Duan, C., Yang, H., White, M. F. & Rui, L. (2004). Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol. Cell. Biol. 24, 7435–43.
46. Dunn, S. L., Bjornholm, M., Bates, S. H., Chen, Z., Seifert, M. & Myers, M. G. Jr. (2005). Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol. Endocrinol. 19, 925–38.
47. Durakoglugil, M., Irving, A. J. & Harvey, J. (2005). Leptin induces a novel form of NMDA receptor-dependent long-term depression. J. Neurochem. 95, 396–405.
48. Elchebly, M., Payette, P., Michaliszyn, E. et al. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science283, 1423–5.
49. Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D. & Van Obberghen, E. (2000). SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275, 15 985–91.
50. Eyckerman, S., Broekaert, D., Verhee, A., Vandekerckhove, J. & Tavernier, J. (2000). Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor. FEBS Lett. 486, 33–7.
51. Fasshauer, M., Kralisch, S., Klier, M. et al. (2004). Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J. Endocrinol. 181, 129–38.
52. Fisher, T. L. & White, M. F. (2004). Signaling pathways: the benefits of good communication. Curr. Biol. 14, R1005–7.
53. Flier, J. S. (2006). Neuroscience. Regulating energy balance: the substrate strikes back. Science312, 861–4.
54. Fong, T. M., Mao, C., MacNeil, T. et al. (1997). ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237, 629–31.
55. Foukas, L. C., Claret, M., Pearce, W. et al. (2006). Critical role for the p110alpha phosphoinositide-3 OH kinase in growth and metabolic regulation. Nature441, 366–70.
56. Francis, S. H., Turko, I. V. & Corbin, J. D. (2001). Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol. 65, 1–52.
57. Frederich, R. C., Hamann, A., Anderson, S., Lollmann, B., Lowell, B. B. & Flier, J. S. (1995). Leptin levels reflect body lipid content in mice: evidence for dietinduced resistance to leptin action. Nat. Med. 1, 1211–14.
58. Friedman, J. M. & Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nat. Med. 395, 763–70.
59. Frodin, M. & Gammeltoft, S. (1999). Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151, 65–77.
60. Fruhbeck, G. (2005). Intracellular signaling pathways activated by leptin. Biochem. J. 393, 7–20.
61. Fryer, L. G., Parbu-Patel, A. & Carling, D. (2002). The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct pathways. J. Biol. Chem. 277, 25 226–32.
62. Gabbay, R. A., Sutherland, C., Gnudi, L. et al. (1996). Insulin regulation of PEPCK gene expression does not require activation of the Ras/MAP kinase signaling pathway. J. Biol. Chem. 271, 1890–7.
63. Gamble, J. & Lopaschuk, G. D. (1998). Insulin inhibition of 5’ adenosine monophosphate activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism46, 1270–4.
64. Gingras, A. -C., Raught, B. & Sonenberg, N. (2001). Regulation of translational initiation by FRAP/mTOR. Genes Dev. 15, 807–26.
65. Greene, M. W., Sakaue, H., Wang, L., Alessi, D. R. & Roth, R. A. (2003). Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. J. Biol. Chem. 278, 8199–211.
66. Gual, P., Le Marchand-Brustel, Y. & Tanti, J. F. (2005). Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie87, 99–109.
67. Gum, R. J., Gaede, L. L., Koterski, S. L. et al. (2003). Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes52, 21–8.
68. Han, S. M., Namkoong, C., Jang, P. G. et al. (2005). Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia48, 2170–8.
69. Hardie, D. G., Salt, I. P., Hawley, S. A. & Davies, S. P. (1999). AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338, 717–22.
70. Harrington, L. S., Findlay, G. M., Gray, A. et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213–23.
71. Harvey, J., McKay, N. G., Walker, K. S., Downes, C. P. & Ashford, M. L. J. (2000). Essential role of phosphoinositide 3-kinase in leptin-induced KATP channel activation in the rat CRI-G1 insulinoma cell line. J. Biol. Chem. 275, 4660–9.
72. Havrankova, J., Roth, J. & Brownstein, M. (1978). Insulin receptors are widely distributed in the central nervous system of the rat. Nature272, 827–9.
73. Hawkins, P. T., Jackson, T. R. & Stephens, L. R. (1992). Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature358, 157–9.
74. Hawley, S. A., Gadalla, A. E., Olsen, G. S. & Hardie, D. G. (2003). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide independent mechanism. Diabetes51, 2420–5.
75. Hegyi, K., Fulop, K., Kovacs, K., Toth, S. & Falus, A. (2004). Leptin-induced signal transduction pathways. Cell Biol. Int. 28, 159–69.
76. Heitman, J., Movva, N. R. & Hall, M. N. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science253, 905–9.
77. Hekerman, P., Zeidler, J., Bamberg-Lemper, S. et al. (2005). Pleiotropy of leptin receptor signaling is defined by distinct roles of the intracellular tyrosines. FEBS J. 272, 109–19.
78. Hennige, A. M., Stefan, N., Kapp, K. et al. (2006). Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB JEpub.
79. Hers, I. & Tavare, J. M. (2005). Mechanism of feedback regulation of IRS1 phosphorylation in primary adipocytes. Biochem. J. 388, 713–20.
80. Hileman, S. M., Pierroz, D. D., Masuzaki, H. et al. (2002). Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology143, 775–83.
81. Hirosumi, J., Tuncman, G., Chang, L. et al. (2002). A central role for JNK in obesity and insulin resistance. Nature420, 333–6.
82. Horie, Y., Suzuki, A., Kataoka, E. et al. (2004). Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–83.
83. Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. (1993). Adipose expression of TNF-a: direct role in obesity-linked insulin resistance. Science259, 87–91.
84. Howard, J. K., Cave, B. J., Oksanen, L. J., Tzameli, I., Bjorbaek, C. & Flier, J. S. (2004). Enhanced leptin sensitivity and attenuation of diet induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10, 734–8.
85. Hu, T. P., Xu, F. P., Li, Y. J. & Luo, J. D. (2006). Simvastatin inhibits leptin-induced hypertrophy in cultured neonatal rat cardiomyocytes. Acta Pharmacol. Sin. 27, 419–22.
86. Huang, W., Dedousis, N., Bhatt, B. A. & O’Doherty, R. M. (2004). Impaired activation of PI 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in dietinduced obesity. J. Biol. Chem. 279, 21 695–700.
87. Ihle, J. N. & Kerr, I. M. (1995). Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69–74.
88. Irving, A. J., Wallace, L., Durakoglugil, D. & Harvey, J. (2006). Leptin enhances NR2B mediated N-methyl-D-aspartate responses via a mitogen-activated protein kinase dependent process in cerebellar granule cells. Neuroscience138, 1137–48.
89. Ishihara, H., Sasaoka, T., Kagawa, S. et al. (2003). Association of the polymorphisms in the 5’ untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett. 554, 450–4.
90. Jefferies, H. B. J., Reinhard, C., Kozma, S. C. & Thomas, G. (1994). Rapamycin selectively represses translation of the ‘polypyrimidine tract ’ mRNA family. Proc. Natl. Acad. Sci. 91, 4441–5.
91. Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B. & Thomas, G. (1997). Rapamycin suppresses 5’TOP mRNA translation through inhibition of p70S6K. EMBO J. 16, 3693–704.
92. Jiang, N., He, T. C., Miyajima, A. & Wojchowski, D. M. (1996). The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta receptor chimera. J. Biol. Chem. 271, 16 472–6.
93. Jo, Y. H., Chen, Y. J., Chua, S. C. Jr., Talmage, D. A. & Role, L. W. (2005). Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron48, 1055–66.
94. Kaburagi, Y., Yamauchi, T., Yamamoto-Honda, R. et al. (1999). The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family. Endocr. J. 46, S25–34.
95. Kagawa, S., Sasaoka, T., Yaguchi, S. et al. (2005). Impact of SRC homology 2-containing inositol 5’ phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90, 2911–19.
96. Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15–25.
97. Kahn, C. R. & White, M. F. (1988). The insulin receptor and the molecular mechanism of insulin action. J. Clin. Invest. 82, 1151–6.
98. Kaisaki, P. J., Delepine, M., Woon, P. Y. et al. (2004). Polymorphisms in type II SH2 domain containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes53, 1900–4.
99. Kapeller, R. & Cantley, L. C. (1994). PI 3-kinase. Bioessays16, 565–76.
100. Kaszubska, W., Falls, H. D., Schaefer, V. G. et al. (2002). Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol. Cell. Endocrinol. 195, 109–18.
101. Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J. & Waterfield, M. D. (2001). Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17, 615–75.
102. Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N. & Ranganathan, G. (2003). Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes52, 1779–85.
103. Khamzina, L., Veilleux, A., Bergeron, S. & Marette, A. (2005). Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology146, 1473–81.
104. Kim, J. K., Fillmore, J. J., Sunshine, M. J. et al. (2004). PKC-theta knockout mice are protected from fat induced insulin resistance. J. Clin. Invest. 114, 823–7.
105. Kitamura, T., Kitamura, Y., Kuroda, S. et al. (1999). Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine threonine kinase Akt Mol. Cell. Biol. 19, 6286–96.
106. Kitamura, T., Feng, Y., Ido, X. et al. (2006). Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12, 534–40.
107. Klaman, L. D., Boss, O., Peroni, O. D. et al. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol.Cell. Biol. 20, 5479–89.
108. Kong, M., Wang, C. S. & Donohue, D. G. (2002). Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J. Biol. Chem. 277, 15 962–70.
109. Krieger-Brauer, H. I. & Kather, H. (1992). Human fat cells possess a plasma membrane bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest. 89, 1006–13.
110. Ktori, C., Shepherd, P. R. & O’Rourke, L. (2003). TNF-alpha and leptin activate the alpha-isoform of class II phosphoinositide 3-kinase. Biochem. Biophys. Res. Commun. 306, 139–43.
111. Kubota, N., Terauchi, Y., Tobe, K. et al. (2004). Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J. Clin. Invest. 114, 917–27.
112. Kurlawalla-Martinez, C., Stiles, B., Wang, Y., Devaskar, S. U., Kahn, B. B. & Wu, H. (2005). Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 25, 2498–510.
113. Kyriakis, J. M., App, H., Zhang, X. F. et al. (1992). Raf-1 activates MAP kinase-kinase. Nature358, 417–21.
114. Lammert, A., Kiess, W., Bottner, A., Glasow, A. & Kratzsch, J. (2001). Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem. Biophys. Res. Commun. 283, 982–8.
115. Lazar, D. F. & Saltiel, A. R. (2006). Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat. Rev. Drug Discov. 5, 333–42.
116. Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P. & Parker, P. J. (1998). PKC isotypes controlled by PI 3-kinase through the protein kinase PDK1. Science281, 2042–5.
117. Le, M. N., Kohanski, R. A., Wang, L. H. & Sadowski, H. B. (2002). Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Mol. Endocrinol. 16, 2764–79.
118. Lee, G. H., Proenca, R., Montez, J. M. et al. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature379, 632–5.
119. Lee, Y. H., Giraud, J., Davis, R. J. & White, M. F. (2003). c-Jun N-terminal kinase(JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem.278, 2896–902.
120. Leslie, N. R. & Downes, C. P. (2004). PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1–11.
121. Lin, X., Taguchi, A., Park, S. et al. (2004). Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Invest. 114, 908–16.
122. Liu, G. (2004). Technology evaluation: ISIS-113715, Isis. Curr. Opin. Mol. Ther. 6, 331–6.
123. Liu, L., Karkanias, G. B., Morales, J. C. et al. (1998). Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273, 31 160–7.
124. Lizcano, J.M. & Alessi, D.R. (2002). The insulin signaling pathway. Curr. Biol. 12, R236–8.
125. Lo, Y. T., Tsao, C. J., Liu, I. M., Liou, S. S. & Cheng, J. T. (2004). Increase of PTEN gene expression in insulin resistance. Horm. Metab. Res. 36, 662–6.
126. Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G. & Sutherland, C. (2000). AICAR mimics the effects of insulin on the expression of 2 key gluconeogenic genes PEPCK and G6Pase. Diabetes49, 896–903.
127. Lund, I. K., Hansen, J. A., Andersen, H. S., Moller, N. P. & Billestrup, N. (2005). Mechanism of protein tyrosine phosphatase 1B mediated inhibition of leptin signaling. J. Mol. Endocrinol. 34, 339–51.
128. Machinal-Quelin, F., Dieudonne, M. N., Leneveu, M. C., Pecquery, R. & Giudicelli, Y. (2002). Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. Am. J. Physiol. Cell Physiol. 282, C853–63.
129. Mahadev, K., Wu, X., Zilbering, A., Zhu, L., Lawrence, J. T. & Goldstein, B. J. (2001a). Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 276, 48 662–9.
130. Mahadev, K., Zilbering, A., Zhu, L. & Goldstein, B. J. (2001b). Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276, 21 938–42.
131. Manganiello, V. & Vaughan, M. (1973). An effect of insulin on cyclic adenosine 3’:5’monophosphate phosphodiesterase activity in fat cells. J. Biol. Chem. 248, 7164–70.
132. Marks, J. L., Porte, D., Stahl, W. L. & Baskin, D. G. (1990). Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology127, 3234–6.
133. Maroni, P., Bendinelli, P. & Piccoletti, R. (2003). Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol. Cell. Endocrinol. 201, 109–21.
134. Maroni, P., Bendinelli, P. & Piccoletti, R. (2005). Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol. Int. 29, 542–50.
135. Martin, D. E. & Hall, M. N. (2005). The expanding TOR signaling network. Curr. Opin. Cell Biol. 17, 158–66.
136. McClung, J. P., Roneker, C. A., Mu, W. et al. (2004). Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA101, 8852–7.
137. McCrimmon, R. J., Fan, X., Ding, Y., Zhu, W., Jacob, R. J. & Sherwin, R. S. (2004). Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes53, 1953–8.
138. Merrill, G. M., Kurth, E. J., Hardie, D. G. & Winder, W. W. (1997). AICA riboside increases AMP-activated kinase, fatty acid oxidation and glucose uptake in rat muscle. Am. J. Physiol. 273, E1107–12.
139. Messina, J. L. & Weinstock, R. S. (1994). Evidence for diverse roles of PKC in the inhibition of gene expression by insulin. Endocrinology135, 2327–34.
140. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Muller, C., Carling, D. & Kahn, B. B. (2002). Lepin stimulates fatty-acid oxidation by activating AMPK. Nature415, 339–43.
141. Minokoshi, Y., Alquier, T., Furukawa, N. et al. (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature428, 569–74.
142. Mirshamsi, S., Laidlaw, H. A., Ning, K. et al. (2004). Leptin and insulin stimulation of signaling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation. BMC Neurosci. 5, 54.
143. Moodie, S. A., Willumsen, B. M., Weber, M. J. & Wolfman, A. (1993). Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science260, 1658–61.
144. Morel, Y. & Barouki, R. (1999). Repression of gene expression by oxidative stress. Biochem. J. 342, 481–96.
145. Mori, H., Hanada, R., Hanada, T. et al. (2004). Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10, 739–43.
146. Morino, K., Petersen, K. F., Dufour, S. et al. (2005). Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587–93.
147. Morton, G. J. & Schwartz, M. W. (2001). The NPY/AgRP neuron and energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25, S56–62.
148. Munzberg, H. & Myers, M. G. Jr. (2005). Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 5, 566–70.
149. Munzberg, H., Huo, L., Nillni, E. A., Hollenberg, A. N. & Bjorbaek, C. (2003). Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology144, 2121–31.
150. Munzberg, H., Bjornholm, M., Bates, S. H. & Myers, M. G. Jr. (2005). Leptin receptor action and mechanisms of leptin resistance. Cell. Mol. Life Sci. 62, 642–52.
151. Murakami, S., Sasaoka, T., Wada, T. et al. (2004). Impact of Src homology 2- containing inositol 5’ phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3 L1 adipocytes cultured with excess amino acids. Endocrinology145, 3215–23.
152. Myers, M. P., Andersen, J. N., Cheng, A. et al. (2001). TYK2 and JAK2 are substrates of protein tyrosine phosphatase 1B. J. Biol. Chem. 276, 47 771–4.
153. Ning, K., Miller, L. C., Laidlaw, H. A. et al. (2006). A novel leptin signaling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO J. doi:10.1038/sj.embboj.7601118.
154. Niswender, K. D. & Schwartz, M. W. (2003). Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front. Neuroendocrinol. 24, 1–10.
155. Niswender, K. D., Morton, G. J., Stearns, W. H., Rhodes, C. J., Myers, M. G. Jr. & Schwartz, M. W. (2001). Intracellular signaling. Key enzyme in leptin-induced anorexia. Nature413, 794–5.
156. Niswender, K. D., Morrison, C. D., Clegg, D. J. et al. (2003). Insulin activation of phosphatidylinositol 3 kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes52, 227–31.
157. Niswender, K. D., Baskin, D. G. & Schwartz, M. W. (2004). Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol. Metab. 15, 362–9.
158. O’Brien, K. B., O’Shea, J. J. & Carter-Su, C. (2002). SH2-B family members differentially regulate JAK family tyrosine kinases. J. Biol. Chem. 277, 8673–81.
159. Ohtsuka, S., Takaki, S., Iseki, M. et al. (2002). SH2-B is required for both male and female reproduction. Mol. Cell. Biol. 22, 3066–77.
160. Ollmann, M. M., Wilson, B. D., Yang, Y. K. et al. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti related protein. Science278, 135–8.
161. O’Malley, D. & Harvey, J. (2004). Insulin activates native and recombinant large conductance Ca2þ-activated potassium channels via a mitogen-activated protein kinase-dependent process. Mol. Pharmacol. 65, 1352–63.
162. Onuma, M., Bub, J. D., Rummel, T. L. & Iwamoto, Y. (2003). Prostate cancer cell adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2 terminal kinase. J. Biol. Chem. 278, 42 660–7.
163. Orci, L., Cook, W. S., Ravazzola, M. et al. (2004). Rapid transformation of white adipocytes into fat oxidising machines. Proc. Natl. Acad. Sci. USA101, 2058–63.
164. Parekh, D., Ziegler, W., Yonezawa, K., Hara, K. & Parker, P. J. (1999). Mammalian TOR controls one of two kinase pathways acting upon nPKCd and nPKCe. J. Biol. Chem. 274, 34 758–64.
165. Parekh, D. B., Ziegler, W., Yonezawa, K., Hara, K. & Parker, P. J. (2000). Multiple pathways control PKC phosphorylation. EMBO J. 19, 496–503.
166. Patel, S., Lipina, C. & Sutherland, C. (2003). Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response element. FEBS Lett549, 72–6.
167. Pawson, T. (1995). Protein modules and insulin signaling networks. Nature373, 573–80.
168. Pawson, T. (2004). Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell116, 191–203.
169. Pawson, T. & Scott, J. D. (1997). Signaling through scaffold, anchoring, and adaptor proteins. Science278, 2075–80.
170. Pearson, G., Robinson, F., Beers, M. et al. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrin. Rev. 22, 153–83.
171. Pei, Z., Liu, G., Lubben, T. H. & Szczepankiewicz, B. G. (2004). Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity. Curr. Pharm. Des. 10, 3481–504.
172. Pelicci, G., Lanfrancone, L., Grignani, F. et al. (1992). A novel transforming protein (SHC)with an SH2 domain is implicated in mitogenic signal transduction. Cell70, 93–104.
173. Phillips, M. S., Liu, Q., Hammond, H. A. et al. (1996). Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13, 18–19.
174. Pocai, A., Lam, T. K. T., Gutierrez-Juarez, R. et al. (2005a). Hypothalamic KATP channels control hepatic glucose production. Nature434, 1026–31.
175. Pocai, A., Morgan, K., Buettner, C., Gutierrez-Juarez, R., Obici, S. & Rossetti, L. (2005b). Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes54, 3182–9.
176. Potashnik, R., Bloch-Damti, A., Bashan, N. & Rudich, A. (2003). IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia46, 639–48.
177. Prasad, R. K. & Ismail-Beigi, F. (1999). Mechanism of stimulation of glucose transport by H2O2: role of PLC. Arch. Biochem. Biophys.362, 113–22.
178. Rahmouni, K. & Haynes, W. G. (2004). Leptin and the cardiovascular system. Rec. Prog. Horm. Res. 59, 225–44.
179. Ravichandran, L. V., Chen, H., Li, Y. & Quon, M. J. (2001). Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol. Endocrinol. 15, 1768–80.
180. Ren, D., Li, M., Duan, C. & Rui, L. (2005). Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2, 95–104.
181. Rieusset, J., Bouzakri, K., Chevillotte, E. et al. (2004). Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes53, 2232–41.
182. Rui, L., Mathews, L. S., Hotta, K., Gustafson, T. A. & Carter-Su, C. M. (1997). Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 17, 6633–44.
183. Rui, L., Herrington, J. & Carter-Su, C. (1999). SH2-B is required for nerve growth factor induced neuronal differentiation. J. Biol. Chem. 274, 10 590–4.
184. Ruiz-Alcaraz, A. J., Liu, H. K., Cuthbertson, D. J. et al. (2005). A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. Biochem. J. 392, 345–52.
185. Sahu, A. (2004). Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front. Neuroendocrinol. 24, 225–53.
186. Sahu, A. & Metlakunta, A. S. (2005). Hypothalamic phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic & pathway of leptin signaling is impaired following chronic central leptin infusion. J. Neuroendocrinol. 17, 720–6.
187. Salt, I. P., Connell, J. M. & Gould, G. W. (2000). 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes49, 1649–56.
188. Sasaoka, T., Wada, T., Fukui, K. et al. (2004). SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J. Biol. Chem. 279, 14835–43.
189. Shanley, L. J., Irving, A. J. & Harvey, J. (2001). Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J. Neurosci. 21, RC186.
190. Shanley, L. J., O’Malley, D., Irving, A. J., Ashford, M. L. J. & Harvey, J. (2002). Leptin inhibits epileptiform-like activity in rat hippocampal neurones via PI 3-kinasedriven activation of BK channels. J. Physiol. 545, 933–44.
191. Shaw, R. J., Lamia, K. A., Vasquez, D. et al. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science310, 1642–6.
192. Shepherd, P. R., Withers, D. J. & Siddle, K. (1998). Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem. J. 333, 471–90.
193. Shi, H., Cave, B., Inouye, K., Bjorbaek, C. & Flier, J. S. (2006). Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes55, 699–707.
194. Shin, H. J., Oh, J., Kang, S. M. et al. (2005). Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 329, 18–24.
195. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171–6.
196. Sleeman, M. W., Wortley, K. E., Lai, K. M. et al. (2005). Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11, 199–205.
197. Spangenburg, E. E., Brown, D. A., Johnson, M. S. & Moore, R. L. (2006). Exercise increases SOCS-3 expression in skeletal muscle: potential relationship to IL-6 expression. J. Physiol. Epub.
198. Standaert, M. L., Galloway, L., Karnam, P., Bandyopadhyay, G., Moscat, J. & Farese, R. V. (1997). Protein kinase C-z as a downstream effector of phosphatidylinositol 3 kinase during insulin stimulation in rat adipocytes. J. Biol. Chem.272, 30 075–82.
199. Stanley, B. G., Kyrkouli, S. E., Lampert, S. & Leibowitz, S. F. (1986). Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides7, 1189–92.
200. Starr, R., Willson, T. A., Viney, E. M. et al. (1997). A family of cytokine-inducible inhibitors of signaling. Nature387, 917–21.
201. Stephens, L. R., Hughes, K. T. & Irvine, R. F. (1991). Pathway of phosphatidylinositol (3,4,5)-trisphosphate synthesis in activated neutrophils. Nature351, 33–9.
202. Stiles, B., Wang, Y., Stahl, A. et al. (2004). Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. USA101, 2082–7.
203. Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M. & Hancock, J. F. (1994). Activation of Raf as a result of recruitment to the plasma membrane. Science264, 1463–7.
204. Sturgill, T. W., Ray, L. B., Erikson, E. & Maller, J. L. (1988). Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature334, 715–18.
205. Sutherland, C., O’Brien, R. M. & Granner, D. K. (1995). Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. J. Biol. Chem.270, 15 501–6.
206. Sutherland, C., Tebbey, P. W. & Granner, D. K. (1997). Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells. Diabetes46, 17–22.
207. Suzuki, R., Tobe, K., Aoyama, M. et al. (2004). Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J. Biol. Chem. 279, 25 039–49.
208. Sweeney, G. (2002). Leptin signaling. Cell Signal. 14, 655–63.
209. Szanto, J. & Kahn, C. R. (2000). Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc. Natl. Acad. Sci. USA97, 2355–60.
210. Taler, M., Shpungin, S., Salem, Y., Malovani, H., Pasder, O. & Nir, U. (2003). Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells. Mol. Endocrinol. 17, 1580–92.
211. Tanabe, K., Okuya, O., Tanizawa, Y., Matsutani, A. & Oka, Y. (1997). Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogenactivated protein kinase. Biochem. Biophys. Res. Commun. 241, 765–8.
212. Tao, J., Malbon, C. C. & Wang, H. Y. (2001). Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo. J. Biol. Chem. 276, 29 520–5.
213. Tartaglia, L. A., Dembski, M., Weng, X. et al. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell83, 1263–71.
214. Taylor, S. D. & Hill, B. (2004). Recent advances in protein tyrosine phosphatase 1B inhibitors. Expert Opin. Investig. Drugs13, 199–214.
215. Toker, A., Meyer, M., Reddy, K. K. et al. (1994). Activation of PKC family members by the novel polyphosphoinositides PI-3,4-P2 and PI-3,4,5-P3. J. Biol. Chem. 269, 32 358–67.
216. Uchida, T., Myers Jr, M. G. & White, M. F. (2000). IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis. Mol. Cell. Biol. 20, 126–38.
217. Ueno, M., Carvalheira, J. B., Tambascia, R. C. et al. (2005). Regulation of insulin signaling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia48, 506–18.
218. Ui, M., Okada, T., Hazeki, K. & Hazeki, O. (1995). Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem. Sci.20, 303–7.
219. Um, S. H., Frigerio, M., Watanabe, M. et al. (2004). Absence of S6K1 protects against ageand diet-induced obesity while enhancing insulin sensitivity. Nature431, 200–5.
220. van den Brink, G. R., O’Toole, T., Hardwick, J. C. et al. (2000). Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol. Cell. Biol. Res. Commun. 4, 144–50.
221. Vanhaesebroeck, B., Leevers, S. J., Panayotou, G. & Waterfield, M. D. (1997). Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22, 267–72.
222. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K. et al. (2001). Synthesis and function of 3 phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535–602.
223. Vlahos, C. J., Matter, W. F., Hui, K. Y. & Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002). J. Biol. Chem. 269, 5241–8.
224. von Manteuffel, S. R., Dennis, P. B., Pullen, N., Gingras, A. C., Sonenberg, N. & Thomas, G. (1997). The insulin-induced signaling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol. Cell. Biol. 17, 5426–36.
225. Wang, J. & Riedel, H. (1998). Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter. J. Biol. Chem. 273, 3136–9.
226. White, M. F. (1998). The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182, 3–11.
227. White, M. F. (2002). IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E413–22.
228. White, M. F. & Kahn, C.R. (1994). The insulin signaling system. J. Biol. Chem. 269, 1–4.
229. Whitehurst, A. W., Wilsbacher, J. L., You, Y., Luby-Phelps, K., Moore, M. S. & Cobb, M. H. (2002). ERK2 enters the nucleus by a carrier independent mechanism. Proc. Natl. Acad. Sci. USA99, 7496–501.
230. Wick, M. J., Dong, L. Q., Hu, D., Langlais, P. & Liu, F. (2001). Insulin-receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GAP and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J. Biol. Chem. 278, 42 843–50.
231. Wijesekara, N., Konrad, D., Eweida, M. et al. (2005). Muscle specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25, 1135–45.
232. Williams, A. G., Hargreaves, A. C., Gunn-Moore, F. J. & Tavare, J. M. (1998). Stimulation of NPY gene expression by BDNF requires both the PLCg and shc binding sites on its receptor, TrkB. Biochem. J. 333, 505–9.
233. Williams, M. R., Arthur, J. S., Balendran, A. et al. (2000). The role of 3- phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439–48.
234. Withers, D. J. & White, M. (2000). Perspective: the insulin signaling system – a common link in the pathogenesis of type 2 diabetes. Endocrinology141, 1917–21.
235. Witters, L. A. & Kemp, B. E. (1992). Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 50-AMP-activated protein kinase. J. Biol. Chem.267, 2864–7.
236. Wynne, K., Stanley, S., McGowan, B. & Bloom, S. (2005). Appetite control. J. Endocrinol. 184, 291–318.
237. Yamagishi, S. I., Edelstein, D., Du, X. L., Kaneda, Y., Guzman, M. & Brownlee, M. (2001). Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276, 25096–100.
238. Yamanashi, Y. & Baltimore, D. (1997). Identification of the Abl- and rasGAPassociated 62 kDa protein as a docking protein, Dok. Cell88, 205–11.
239. Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A. et al. (2002). PTP1B regulates leptin signal transduction in vivo. Dev. Cell2, 489–95.
240. Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F. & Jeanrenaud, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology133, 1753–8.
241. Zhang, E. E., Chapeau, E., Hagihara, K. & Feng, G. S. (2004). Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. USA101, 16064–9.
242. Zhang, W., Zong, C. S., Hermanto, U., Lopez-Bergami, P., Ronai, Z. & Wang, L. H. (2006). RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorageindependent growth. Mol. Cell. Biol. 26, 413–24.
243. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature372, 425–32.
244. Zhao, A. Z., Bornfeldt, K. E. & Beavo, J. A. (1998). Leptin inhibits insulin secretion by activation of PDE 3B. J. Clin. Invest. 102, 869–73.
245. Zhao, A. Z., Shinohara, M. M., Huang, D. et al. (2000). Leptin induces insulin-like signaling that antagonises cAMP elevation by glucagon in hepatocytes. J. Biol. Chem. 275, 11 348–54.
246. Zhao, A. Z., Huan, J. N., Gupta, S., Pal, R. & Sahu, A. (2002). A phosphatidylinositol 3 kinase phosphodiesterase 3B-cyclic & pathway in hypothalamic action of leptin on feeding. Nat. Neurosci. 5, 727–8.
247. Zheng, C. F. & Guan, K. L. (1994). Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. Embo. J. 13, 1123–31.
248. Zinker, B. A., Rondinone, C. M., Trevillyan, J. M. et al. (2002). PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA99, 11 357–62.
249. Zong, H., Ren, J. M., Young, L. H. et al. (2002). & kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA99, 15 983–7.